Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study.

Merav Heshin-Bekenstein,Amit Ziv,Natasa Toplak, Siman Lazauskas,Danielle Kadishevich, Efrat Ben-Nun Yaari,Adi Miller-Barmak,Yonatan Butbul Aviel,Esther Saiag,Sara Pel,Ori Elkayam,Yosef Uziel,Victoria Furer

Vaccines（2023）

Cited 0|Views21
No score
Abstract
The safety profile of three doses of the BNT162b2 mRNA vaccine was excellent, with adequate humoral response and similar efficacy among patients and controls. These results support the recommendation for vaccinating adolescents with juvenile-onset AIIRDs against COVID-19.
More
Translated text
Key words
COVID-19,adolescent,biologics,immunomodulatory medications,juvenile-onset rheumatic diseases,pediatric rheumatology,safety,vaccines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined